Highlighted publications
PET/CT-guided management of immune checkpoint blockade and multi-modal profiling following treatment in long-term responders with metastatic lung cancer in the National Network Genomic Medicine Lung Cancer Germany (nNGM)
N. Frost, M. Joosten, J. Franzen, M. Wiesweg, A. Rasokat, J. Kulhavy, J. Kollmeier, N. Reinmuth, C. Grohé, J. Roeper, A. Rittmeyer, S. Heinzen, M. Wermke, C. Wesseler, P. Christopoulos, D. Kauffmann-Guerrero, A. Althoff, A. Bleckmann, M. Collienne, E. Berezucki, T. Overbeck, C. Kropf-Sanchen, F. Griesinger, M. Sebastian, M. Schuler, S. Braun, C. Wenzel, C. Furth, J. Wolf, P. Bischoff*, M. Reck* for the National Network Genomic Medicine Lung Cancer Collaborator Group
Annals of Oncology 2026
Outcome of First-Line Treatment With Pembrolizumab According to KRAS/TP53 Mutational Status for Nonsquamous Programmed Death-Ligand 1-High (>/=50%) NSCLC in the German National Network Genomic Medicine Lung Cancer
P. Bischoff*, M. Reck*, T. Overbeck, P. Christopoulos, A. Rittmeyer, H. Luders, J. Kollmeier, J. Kulhavy, M. Kemper, N. Reinmuth, J. Roper, M. Janning, L. Sommer, L. Aguinarte, M. Koch, M. Wiesweg, C. Wesseler, C. F. Waller, D. Kauffmann-Guerrero, A. Stenzinger, S. Stephan-Falkenau, M. Trautmann, S. Lassmann, M. Tiemann, F. Klauschen, M. Sebastian, F. Griesinger, J. Wolf, S. Loges, N. Frost for the National Network Genomic Medicine Lung Cancer Collaborator Group
Journal of Thoracic Oncology 2024
Robust detection of clinically relevant features in single-cell RNA profiles of patient-matched fresh and formalin-fixed paraffin-embedded (FFPE) lung cancer tissue
A. Trinks, M. Milek, D. Beule, J. Kluge, S. Florian, C. Sers, D. Horst, M. Morkel*, P. Bischoff*
Cellular Oncology 2024
Single-cell RNA sequencing reveals distinct tumor microenvironmental patterns in lung adenocarcinoma
P. Bischoff, A. Trinks, B. Obermayer, J. P. Pett, J. Wiederspahn, F. Uhlitz, X. Liang, A. Lehmann, P. Jurmeister, A. Elsner, T. Dziodzio, J.-C. Rückert, J. Neudecker, C. Falk, D. Beule, C. Sers, M. Morkel, D. Horst, N. Blüthgen, F. Klauschen
Oncogene 2021 — This publication is part of Readers Choice: The best of Oncogene 2021